Maharashtra: Maharashtra Chief Minister Devendra Fadnavis on Tuesday informed the Assembly that the state government will soon make empanelment under central and state health schemes mandatory for all charitable hospitals.…
Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to…
DOJ is backing AbbVie in its battle to overturn a Colorado law that prohibits pharmaceutical companies from placing restrictions on the 340B drug discount program.
New Delhi: The Supreme Court sought responses from the Union government and the Drug Controller General of India regarding an appeal filed by Micro Labs against the prohibition of two…
New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets USP…
Mumbai: Indian drugmaker Dr Reddy's Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with…
Lucknow: The Allahabad High Court has refused to grant regular bail to two individuals accused in a case involving the alleged illegal storage and transportation of Phensedyl cough syrup, effectively…
New Delhi: Aurobindo Pharma Limited announced that its wholly owned subsidiary, Eugia Pharma Specialities Limited, has received final approval from the US Food and Drug Administration (USFDA) for Everolimus Tablets…
FDA Commissioner Marty Makary defended the agency’s recent rejections of rare disease drugs and one of his deputies, Vinay Prasad, in an interview with CNBC.
A new study published in the journal of BMC Surgery showed that shorter operational time, less intraoperative blood loss, a shorter postoperative hospital stays, and a higher textbook outcome (TO)…